ELCC 2023 on Long-Term Efficacy, Safety & Predictors of Response to Amivantamab Among Patients With Post-Platinum EGFR ex20ins-Mutated Advanced NSCLC

By ecancer FEATURING Nicolas Girard
By ecancer FEATURING Nicolas Girard
440 views
May 9, 2023
Comments 0
Login to view comments. Click here to Login